story of the week
Preventive PCI vs Optimal Medical Therapy Alone for the Treatment of Vulnerable Atherosclerotic Coronary Plaques
Sign in to PracticeUpdate
Only registered members have full access to PracticeUpdate content.
Additional Info
Disclosure statements are available on the authors' profiles:
The Lancet
From MEDLINE®/PubMed®, a database of the U.S. National Library of Medicine.
Preventive percutaneous coronary intervention versus optimal medical therapy alone for the treatment of vulnerable atherosclerotic coronary plaques (PREVENT): a multicentre, open-label, randomised controlled trial
Lancet 2024 Apr 04;[EPub Ahead of Print], SJ Park, JM Ahn, DY Kang, SC Yun, YK Ahn, WJ Kim, CW Nam, JO Jeong, IH Chae, H Shiomi, HL Kao, JY Hahn, SH Her, BK Lee, TH Ahn, KY Chang, JK Chae, D Smyth, GS Mintz, GW Stone, DW ParkFrom MEDLINE®/PubMed®, a database of the U.S. National Library of Medicine.